a public good project by the
Synthesis
Company
of California

© 2026

Susan M. Ludeman | doi.page

0 works0 citations0 h-index

Susan M. Ludeman

Albany College of Pharmacy and Health Sciences(US)

Publications by Year

Research Areas

Chemotherapy-induced organ toxicity mitigation, Organophosphorus compounds synthesis, Chemical Reactions and Isotopes, Acute Lymphoblastic Leukemia research, Carcinogens and Genotoxicity Assessment

Most-Cited Works

→ Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity(1999)534 cited
→ The Chemistry of the Metabolites of Cyclophosphamide(1999)151 cited
→ Short-term exposure of human ovarian follicles to cyclophosphamide metabolites seems to promote follicular activation in vitro(2016)103 cited
→ DRUG FOCUS: Pharmacogenetic Studies Related to Cyclophosphamide-Based Therapy(2009)86 cited
→ Phosphorus-31 nuclear magnetic resonance spectroscopic observation of the intracellular transformations of oncostatic cyclophosphamide metabolites(1986)57 cited
→ Modulation of cyclophosphamide activity by O ? 6 -alkylguanine-DNA alkyltransferase(1999)55 cited
→

NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. A comprehensive kinetic analysis of the interconversion of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and the concomitant partitioning of aldophosphamide between irreversible fragmentation and reversible conjugation pathways

(1984)

50 cited

Intraneoplastic polymer-based delivery of cyclophosphamide for intratumoral bioconversion by a replicating oncolytic viral vector.(2001)

Effect of O6-benzylguanine on alkylating agent-induced toxicity and mutagenicity. In Chinese hamster ovary cells expressing wild-type and mutant O6-alkylguanine-DNA alkyltransferases.(2000)

→ Pharmacodynamic and pharmacokinetic study of chronic low-dose metronomic cyclophosphamide therapy in mice(2007)48 cited